Skip to content
Study details
Enrolling now

Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention

University of Illinois at Chicago
NCT IDNCT06550804ClinicalTrials.gov data as of Apr 2026
Phase

Phase 3

Target enrollment

126

Study length

about 1.8 years

Ages

18+

Locations

1 site in IL

What this study is about

This trial is testing a real-time electronic adherence monitoring intervention called A-TEAM. This intervention uses an electronic pill container to remind people when they should take their medication, and alerts support persons or case managers if the medication isn't taken as scheduled. The goal is to see if this approach is acceptable and feasible for African American men who have sex with men living with HIV.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in A-TEAM

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Viral load suppression

Secondary: Adherence

Body systems

Immune, Infectious